top of page
“Our platform is engineered to cut development costs by up to two-thirds, accelerate lead selection six fold, and because we validate on patient-derived tumoroids double the odds a therapy reaches the clinic.”
Arun Asaithambi, Ph.D.
Founder and CEO

Team.

Anand Asaithambi.
Co-Founder and Tech Advisor
////////////////
////////////////
+
+
+

Santhosh Kumar, Ph.D.
Scientific Program manager

Ragesh J
Devops Engineer

Darilang Mawrie, Ph.D.
Research Associate -Organoid Research

Aakriti Burman
Human Resource
Human Resource

Shreyansh Suyash
Computational Biologist

Gopinath Jayagopal
Computational Chemist
+
+
Mission
Vision
"At Katamaran Industries, our mission is to transform cancer drug discovery by integrating patient-derived tumoroids, advanced automation, and generative AI into one unified, powerful engine for innovation."
"We envision a world where cancer is curable. Drug discovery is broken—our goal is to reinvent it and deliver life-saving therapies faster, smarter, and more precisely than ever before."
Mission + Vision
////////////////
////////////////
+
+
+
“Our platform is engineered to cut development costs by up to two-thirds, accelerate lead selection six fold, and because we validate on patient-derived tumoroids double the odds a therapy reaches the clinic.”
Team.

Arun Asaithambi, Ph.D.
Founder and CEO

Anand Asaithambi
Co-Founder and Tech Advisor
////////////////

We’re looking for collaborators, investors, and visionary scientists. Reach out and be part of the mission.
Follow Us
© 2025 Katamaran Industries. Innovating for global health equity.
Quick Links
Our Address

India :
Unit, #603, 6th floor, Sigmasoft tech park, Gamma block, Whitefeild, Bengaluru, Karnataka, 560066
US :
Unit 419,180 talmadge rd, Edison nj 08817
UK :
41 Clooney Terrace, Londonderry, Northern Ireland, BT47 6AP

Mail :
bottom of page




